$1.44 Million in Sales Expected for Aclaris Therapeutics, Inc. (NASDAQ:ACRS) This Quarter

Retrieved on: 2021-04-14 07:18:45

Tags for this article:

Click the tags to see associated articles and topics

$1.44 Million in Sales Expected for Aclaris Therapeutics, Inc. (NASDAQ:ACRS) This Quarter. View article details on hiswai:

Excerpt

Schonfeld Strategic Advisors LLC now owns 249,200 shares of the biotechnology company's stock valued at $641,000 after purchasing an additional ...

Article found on: www.marketbeat.com